Lipoxygenase Inhibitors for Cancer Prevention: Promises and Risks

E-ISSN： 1873-4286|16|6|725-733

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.6, 2010-02, pp. : 725-733

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential use of lipoxygenase inhibitors for cancer chemoprevention

By Steele V.E. Holmes C.A. Hawk E.T. Kopelovich L. Lubet R.A. Crowell J.A. Sigman C.C. Kelloff G.J.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 9, 2000-09 ,pp. : 2121-2138

Informa Healthcare

Access to resources Recommend Favorite

Aromatase inhibitors and breast cancer prevention

By Litton Jennifer Keating Arun Banu K Brown Powel H Hortobagyi Gabriel N

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. : 325-331

Informa Healthcare

Access to resources Recommend Favorite

The Role of Cyclooxygenase Inhibitors in Cancer Prevention

Current Pharmaceutical Design, Vol. 8, Iss. 12, 2002-06 ,pp. : 1035-1062

Bentham Science Publishers

Access to resources Recommend Favorite

Risks and Benefits of Aromatase Inhibitors in Postmenopausal Breast Cancer

By Michaud L.B.

Drug Safety, Vol. 21, Iss. 4, 1999-10 ,pp. : 297-309

Adis International

Access to resources Recommend Favorite

Cyclooxygenase 2 selective inhibitors in cancer treatment and prevention

By Menter David G

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 12, 2002-12 ,pp. : 1749-1764

Informa Healthcare

Access to resources Recommend Favorite